文献速递血管炎

巨细胞动脉炎中成纤维细胞活化蛋白α的血浆水平改变与组织表达

Altered Plasma Levels and Tissue Expression of Fibroblast Activation Protein Alpha in Giant Cell Arteritis.
PubMed 文献 · Arthritis Care Res (Hoboken) · 2024-06-18

本研究检测了未经治疗的巨细胞动脉炎(GCA)患者血浆成纤维细胞活化蛋白α(FAP)水平及血管组织FAP表达。GCA患者基线血浆FAP水平显著低于风湿性多肌痛患者和健康对照,且与全身炎症和血管生成标志物呈负相关;缓解3个月时FAP进一步下降,无治疗缓解期逐渐升至健康对照水平;炎症颞动脉活检和GCA相关主动脉瘤组织中FAP表达增加。

要点

  • GCA患者基线血浆FAP水平显著低于风湿性多肌痛患者和健康对照。
  • 血浆FAP水平与全身炎症和血管生成标志物呈负相关。
  • 炎症颞动脉和GCA相关主动脉瘤组织中FAP表达增加。

核心结论

  • FAP在GCA中的表达在血浆和血管水平均明显受调控。
  • FAP可能参与GCA的炎症和重塑过程,并可能作为影像学和治疗干预的靶点。

研究设计与样本

  • 研究采用酶联免疫吸附试验检测未经治疗的GCA患者(n=60)、风湿性多肌痛患者(n=63)和年龄性别匹配的健康对照(n=42)的血浆FAP水平,并在随访中包括无治疗缓解期进行检测。
  • 采用免疫组织化学对GCA患者炎症颞动脉活检(n=9)、非炎症颞动脉活检(n=14)、GCA相关动脉瘤(n=9)和动脉粥样硬化相关动脉瘤(n=11)的主动脉样本进行FAP染色。
  • 采用免疫荧光染色检测成纤维细胞(CD90)、巨噬细胞(CD68/CD206/叶酸受体β)、血管平滑肌细胞(结蛋白)、肌成纤维细胞(α-平滑肌肌动蛋白)、白细胞介素-6(IL-6)和基质金属蛋白酶-9(MMP-9)。

主要发现

  • GCA患者基线血浆FAP水平显著低于风湿性多肌痛患者和健康对照,且与全身炎症和血管生成标志物呈负相关。
  • GCA患者缓解3个月时FAP水平进一步下降,在无治疗缓解期逐渐升至健康对照水平。
  • 与对照组织相比,GCA患者炎症颞动脉活检和主动脉中FAP表达增加。
  • FAP在成纤维细胞和巨噬细胞中大量表达,部分FAP+成纤维细胞表达IL-6和MMP-9。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Giant cell arteritis (GCA) is characterized by granulomatous inflammation of the medium- and large-sized arteries accompanied by remodeling of the vessel wall. Fibroblast activation protein alpha (FAP) is a serine protease that promotes both inflammation and fibrosis. Here, we investigated the plasma levels and vascular expression of FAP in GCA. METHODS: Plasma FAP levels were measured with enzyme-linked immunosorbent assay in treatment-naive patients with GCA (n = 60) and polymyalgia rheumatica (PMR) (n = 63) compared with age- and sex-matched healthy controls (HCs) (n = 42) and during follow-up, including treatment-free remission (TFR). Inflamed temporal artery biopsies (TABs) of patients with GCA (n = 9), noninflamed TABs (n = 14), and aorta samples from GCA-related (n = 9) and atherosclerosis-related aneurysm (n = 11) were stained for FAP using immunohistochemistry. Immunofluorescence staining was performed for fibroblasts (CD90), macrophages (CD68/CD206/folate receptor beta), vascular smooth muscle cells (desmin), myofibroblasts (α-smooth muscle actin), interleukin-6 (IL-6), and matrix metalloproteinase-9 (MMP-9). RESULTS: Baseline plasma FAP levels were significantly lower in patients with GCA compared with patients with PMR and HCs and inversely correlated with systemic markers of inflammation and angiogenesis. FAP levels decreased even further at 3 months on remission in patients with GCA and gradually increased to the level of HCs in TFR. FAP expression was increased in inflamed TABs and aorta of patients with GCA compared with control tissues. FAP was abundantly expressed in fibroblasts and macrophages. Some of the FAP+ fibroblasts expressed IL-6 and MMP-9. CONCLUSION: FAP expression in GCA is clearly modulated both in plasma and in vessels. FAP may be involved in the inflammatory and remodeling processes in GCA and have utility as a target for imaging and therapeutic intervention.

来源:Arthritis Care Res (Hoboken),查看原文。版权归原作者所有。

引用

  1. Xu S, Jiemy WF, Boots AMH, et al. Altered Plasma Levels and Tissue Expression of Fibroblast Activation Protein Alpha in Giant Cell Arteritis. Arthritis Care Res (Hoboken). 2024. PMID: 38685696. doi:10.1002/acr.25354

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。